Recharacterization of RSL3 reveals that the selenoproteome is a druggable target in colorectal cancer
Preprint in bioRxiv (April 2024)
The most recent citing publications are shown below. View all 35 publications that cite this research output on Dimensions.
RNA-binding proteins in breast cancer: Biological implications and therapeutic opportunities
Article in Critical Reviews in Oncology/Hematology (January 2024)
Alleviated NCOA4-mediated ferritinophagy protected RA FLSs from ferroptosis in lipopolysaccharide-induced inflammation under hypoxia
Article in Inflammation Research (January 2024)